Evaluation of Oral Alpha-Cyclodextrin for Decreasing Serum Cholesterol
Clinical trial NCT01131299 · COMPLETED
Trial details
- NCT number
- NCT01131299
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2015-02-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.